You just read:

ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy

News provided by

Isis Pharmaceuticals, Inc.

Apr 23, 2013, 07:00 ET